XML 88 R69.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2020
Oct. 31, 2019
Mar. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Mar. 31, 2022
Feb. 28, 2021
Dec. 31, 2018
Subsidiary or Equity Method Investee [Line Items]                  
Weighted average grant date fair value (in Dollars per share)       $ 11.35          
Covid 19, description due to the potential impact on future net sales and operating results resulting from the COVID-19 pandemic, the estimated number of shares to be distributed, after forfeited shares, was reduced from 142,571 to 82,162. As the Company had already purchased shares in contemplation of the higher anticipated distribution, shares purchased in excess of the reduced anticipated distribution were transferred to treasury shares at the Interparfums SA level.                
Percentage of increase in annual dividend   20.00%              
Dividends payable, amount per share (in Dollars per share)   $ 1.32              
Subsequent Event [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Dividends payable, amount per share (in Dollars per share)             $ 0.50    
Interparfums S A Subsidiary [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Adjusted for stock splits (in Shares)       172,343          
Revaluation resulted in reduction of cost, description     The original cost of the grant was approximately $4.4 million, and the March 2020 revaluation resulted in a reduction of the cost, to approximately $2.5 million.             
Modification resulted revised cost       $ 4,600,000          
Board of Directors Chairman [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Dividends payable, amount per share (in Dollars per share)               $ 2.00  
Interparfums S A Subsidiary [Member] | Employees [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Adjusted for stock splits (in Shares)                 26,600
Interparfums S A Subsidiary [Member] | Officers And Managers [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Aggregate intrinsic value of options outstanding                 $ 133,000
Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Number of shares available for grant (in Shares)       612,535          
Aggregate intrinsic value of options outstanding       $ 25,900,000          
Term       5 years          
Stock Option One [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Aggregate intrinsic value of options outstanding       $ 2,900,000          
Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Fair value of shares vested       $ 1,400,000 $ 1,700,000 $ 1,400,000      
Weighted average grant date fair value (in Dollars per share)       $ 11.35 $ 12.16 $ 14.14      
Minimum [Member] | Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Share-based compensation arrangement by share-based payment award, award vesting period       4 years          
Maximum [Member] | Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Share-based compensation arrangement by share-based payment award, award vesting period       5 years